Also known as: Pediatric hepatoblastoma, childhood liver cancer.
What is hepatoblastoma?
A hepatoblastoma is a rare tumor (cancerous- spreads) that grows from the cells of the liver. It’s the most common of liver cancers in childhood, occurring during the first 18 months of life (infants to 5 years of age), in mostly white children, boys, and those born prematurely of low birth weight.
What causes hepatoblastoma?
While the cause is unknown, certain genetic (familial adenomatous polyposis, Beckwith-Wiedemann syndrome) and other medical conditions can put children at a greater risk of getting hepatoblastoma (e.g. hemihyperplasia, hepatitis B infection, biliary atresia).
What are the signs/symptoms of hepatoblastoma?
Signs and symptoms depend on the size of the tumor and whether or not it has spread. They include; a lump in the liver, a swollen abdomen, fever, weight loss, vomiting, reduced appetite, jaundice with yellow skin and eyes, itchiness and/or pale skin color (anemia), and back pain.
What are hepatoblastoma care options?
Treatments include surgery and one or more types of chemotherapy.
Reviewed by: Jack Wolfsdorf, MD, FAAP
This page was last updated on: 5/23/2018 2:23:22 PM
Camp U.O.T.S. is an annual weeklong, overnight camp for children with cancer and blood disorders who are treated at Nicklaus Children’s Hospital.
Learn more and register
From the Newsdesk
More than two dozen children attended the Bear Hug camp at Nicklaus Children's last week. This day camp is for siblings of pediatric cancer patients to encourage socialization among peers and help them gain insight on their siblings' care journey.
On this very same day nine years ago, Daniella Alvarez was diagnosed Teratoid Rhabdoid Tumor (ATRT), a rare and aggressive type of brain cancer. The news came on June 26, 2009, her second birthday. Daniella endured years of brain surgeries, aggressive chemotherapies, radiation, imaging scans, multiple visits to intensive care at Nicklaus Children’s Hospital. She is now cancer free thanks to a pediatric clinical trial made possible through research funding.